DuPont Earnings Beat Estimates, Raises Guidance

DuPontDuPont (DD) reported quarterly results Tuesday morning, and like so many companies so far this earnings season, the third-largest U.S. chemical company beat estimates and raised its outlook.

DuPont said that its second-quarter net income rose to $1.16 billion, or $1.26 a share, from $417 million, or 46 cents a share, in the year-ago period. Excluding significant items, earnings per share totaled $1.17. Analysts had been expecting earnings of 93 cents a share, according to Thomson Reuters.

Net sales climbed 26% to $8.6 billion, from $6.9 billion last year. All segments had double-digit sales increases, with more than 25% volume growth in the Electronics & Communications, Performance Materials, and Safety & Protection segments. Agriculture & Nutrition delivered 16% sales growth, the result of both price and volume increases.

"We grew sales across every segment. Several businesses, including electronics and titanium dioxide, delivered results that far exceeded pre-recession levels. We continue to hit our productivity and cost-control targets, and remain highly disciplined in creating operating leverage to further grow the company," said CEO Ellen Kullman.

DuPont increased its full-year adjusted earnings outlook to a range of $2.90 to $3.05 per share, up from its previous range of $2.50 to $2.70 per share, to reflect strong second-quarter results and expected continuation of year-over-year gains from higher sales, further strengthening of midcycle businesses, the company said.

DuPont's shares jumped over 4% in premarket trading.
Read Full Story


DJIA 24,462.94 -201.95 -0.82%
NASDAQ 7,146.13 -91.93 -1.27%
S&P 500 2,670.14 -22.99 -0.85%
NIKKEI 225 22,162.24 -28.94 -0.13%
HANG SENG 30,418.33 -290.11 -0.94%
DAX 12,540.50 -26.92 -0.21%
USD (per EUR) 1.23 0.00 -0.26%
USD (per CHF) 0.97 0.00 0.02%
JPY (per USD) 107.62 -0.05 -0.04%
GBP (per USD) 1.40 0.00 0.01%

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.